Western blots versus selected reaction monitoring assays: time to turn the tables?
about
The role of proteomics in progressing insights into plant secondary metabolismCytochrome P450 ω-Hydroxylases in Inflammation and CancerEvidence for bladder urothelial pathophysiology in functional bladder disordersOptimized approaches for quantification of drug transporters in tissues and cells by MRM proteomicsGuidelines for the design, analysis and interpretation of 'omics' data: focus on human endometriumBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsOpen tubular lab-on-column/mass spectrometry for targeted proteomics of nanogram sample amountsHeterogeneity of glycolysis in cancers and therapeutic opportunities.Advances in targeted proteomics and applications to biomedical researchVersatile, sensitive liquid chromatography mass spectrometry - Implementation of 10 μm OT columns suitable for small molecules, peptides and proteinsSynthetic Nucleosomes Reveal that GlcNAcylation Modulates Direct Interaction with the FACT ComplexNasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection.Quantitative proteomic analysis of histone modificationsDatabase of Optimized Proteomic Quantitative Methods for Human Drug Disposition-Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling.The proteomic to biology inference, a frequently overlooked concern in the interpretation of proteomic data: a plea for functional validation.Large-scale label-free phosphoproteomics: from technology to data interpretation.Application of wide selected-ion monitoring data-independent acquisition to identify tomato fruit proteins regulated by the CUTIN DEFICIENT2 transcription factor.How may targeted proteomics complement genomic data in breast cancer?LC-MS/MS quantification of sulfotransferases is better than conventional immunogenic methods in determining human liver SULT activities: implication in precision medicine.Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins.Bioinformatic Analysis of Differential Protein Expression in Calu-3 Cells Exposed to Carbon Nanotubes.Global discovery of high-NaCl-induced changes of protein phosphorylationQuantitative proteomics in cardiovascular research: global and targeted strategiesValidating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity.Selected reaction monitoring as an effective method for reliable quantification of disease-associated proteins in maple syrup urine disease.Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution.Correlation of phenotypic profiles using targeted proteomics identifies mycobacterial esx-1 substrates.The Physcomitrella patens Chloroplast Proteome Changes in Response to Protoplastation.Beyond the Western front: targeted proteomics and organelle abundance profilingQuantitative proteome analysis of temporally resolved phagosomes following uptake via key phagocytic receptors.Quantitative mass spectrometry of urinary biomarkersA laser ablation ICP-MS based method for multiplexed immunoblot analysis: applications to manganese-dependent protein dynamics of photosystem II in barley (Hordeum vulgare L.).Mechanisms of Egg Yolk Formation and Implications on Early Life History of White Perch (Morone americana).Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling.Advances in Proteomic Technologies and Its Contribution to the Field of CancerCortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAsAnalysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC)The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Dynamic phosphorylation of RelA on Ser42 and Ser45 in response to TNFα stimulation regulates DNA binding and transcription.
P2860
Q26798447-9342B0F6-E283-4A43-A218-E7DBA12B55CEQ26800210-EE11C829-4594-44D0-BBF1-CD570E499E5EQ26824708-962A7F17-9078-4899-AE1B-71EFF8AA4AE4Q26851693-3CBC1CA7-CD13-4161-A3F3-6B9F2F828125Q27012789-D5F2C789-6585-4E7A-8EC7-C6ECF8845C78Q27024518-CD6DBF53-C9E1-4D7D-A092-4E26CF39B552Q27312175-865E4261-054A-4976-BB2A-B2383461FD67Q27693375-CF1D189F-33C3-4473-B60D-C6476280B9B4Q28066912-01FE698A-2938-44C0-8764-96EA921B91B1Q28818402-59B107A5-37D9-420B-B0AD-EB88FD9E6CAEQ28821291-D263AD99-4286-452F-9E78-903C8530FEA9Q30253085-CF5C52F0-3B66-4636-AF5B-785C7D471C0FQ30375585-53F18B3A-3742-4D40-95F5-302555329D33Q30490654-612A7ECE-13DE-4A6A-8FD9-68ABAD00C55EQ30700824-94B9485B-4607-4F45-A5FC-E6C9AD851560Q30868595-3900413D-AEDF-41DF-BB34-E9AF6376C382Q31080102-B4A6FCD6-2E04-4257-9938-7C85317000B5Q31140924-A4F432D9-2544-4C1E-A323-A744CD842C65Q33818825-5B0F9BC7-7ED0-45BD-8461-1A74EEEBFEA0Q34039613-53073919-3E5D-40D2-9C68-C051972722E9Q34107063-1B0FEECD-E79E-447A-B69E-F6F96A8EA477Q34130865-29E78BC0-9EA9-4E7B-9D84-1A6B9C19661AQ34156082-F86F39F3-B949-4B0B-BE55-17003F1B0373Q34241636-3ABC7BCF-BB09-4E8F-ACB0-3A63638ED12AQ34311107-3BE85153-F957-4477-959C-C576B104F1C0Q34343547-336DA9F7-DF61-4D30-A8E9-B231735DEE1FQ34490258-6A88EC93-9D31-4972-92DB-33BE7D8B1B65Q34679943-F0E56C74-0C7D-42E6-8F69-D836161F8E90Q35569275-7BD44D73-A47F-416A-B194-7096937FA38FQ35583355-B8155D33-F283-4720-9917-46F01C4BFA4FQ35599113-282456E6-4067-4228-8048-F6CB38DB9C99Q35669892-76B6FFA9-22CF-4898-8931-DFFADEEEC16AQ35845350-6AD94EFF-735D-4CEA-BC8A-72A0BBCFE90FQ35857978-73DEE1AF-C852-41CF-BED1-09F9EDDF5024Q35926217-4B1B5F0E-8710-4FA8-854E-D915597EB06AQ36112651-04893C8B-8578-4050-9DEA-1AED9DCE10F3Q36533812-1D9DC695-4CC0-435D-85A1-0F766BA44B55Q36539459-57B9F794-5B32-4BA6-A287-50C6257B583DQ36771005-585EF023-50C9-4DBE-95D9-EF48DA616090Q37141024-9845D618-C391-4EC6-8973-8B5287A88B38
P2860
Western blots versus selected reaction monitoring assays: time to turn the tables?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Western blots versus selected reaction monitoring assays: time to turn the tables?
@en
Western blots versus selected reaction monitoring assays: time to turn the tables?
@nl
type
label
Western blots versus selected reaction monitoring assays: time to turn the tables?
@en
Western blots versus selected reaction monitoring assays: time to turn the tables?
@nl
prefLabel
Western blots versus selected reaction monitoring assays: time to turn the tables?
@en
Western blots versus selected reaction monitoring assays: time to turn the tables?
@nl
P2860
P356
P1476
Western blots versus selected reaction monitoring assays: time to turn the tables?
@en
P2093
Alma L Burlingame
Ralph A Bradshaw
P2860
P304
P356
10.1074/MCP.E113.031658
P577
2013-06-10T00:00:00Z